tiprankstipranks
Trending News
More News >
Advertisement

RSSL - ETF AI Analysis

Compare

Top Page

RSSL

Global X Russell 2000 ETF (RSSL)

Rating:63Neutral
Price Target:
The Global X Russell 2000 ETF (RSSL) has a solid overall rating, reflecting a mix of strong performers and weaker holdings. NEXTracker, Inc. and The Ensign Group stand out as key contributors, driven by robust financial performance, strategic growth, and positive earnings calls. However, weaker holdings like IonQ and Guardant Health, which face financial instability and valuation challenges, slightly weigh down the fund's rating. A notable risk is the ETF's exposure to companies with high valuation concerns, which could impact long-term stability.
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered solid gains so far this year, indicating strong overall momentum.
Low Expense Ratio
The fund charges a very low expense ratio, making it cost-effective for investors.
Broad Sector Diversification
The ETF is spread across multiple sectors, reducing the risk of overexposure to any single industry.
Negative Factors
High Geographic Concentration
Nearly all of the fund’s exposure is in U.S. companies, limiting diversification across global markets.
Small Holdings Weight
Individual holdings make up a very small percentage of the portfolio, which may dilute the impact of strong-performing stocks.
Underperformance in Some Top Holdings
A few of the largest positions have shown weaker year-to-date performance, which could drag on overall returns.

RSSL vs. SPDR S&P 500 ETF (SPY)

RSSL Summary

The Global X Russell 2000 ETF (RSSL) is an investment fund that focuses on small-cap companies in the U.S., tracking the Russell 2000 Index. Small-cap companies are typically younger or growing businesses, often with high potential for innovation and expansion. This ETF includes companies like Bloom Energy and Credo Technology Group, giving investors exposure to emerging industries and leaders. It’s a great option for those looking to diversify their portfolio and tap into the growth potential of smaller companies. However, small-cap stocks can be more volatile than larger companies, meaning their prices can rise or fall quickly depending on market conditions.
How much will it cost me?The Global X Russell 2000 ETF (RSSL) has an expense ratio of 0.08%, which means you’ll pay $0.80 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks the Russell 2000 Index, keeping costs down compared to actively managed funds.
What would affect this ETF?The Global X Russell 2000 ETF could benefit from economic growth and innovation in small-cap sectors like technology and healthcare, which are heavily represented in its holdings. However, it may face challenges from rising interest rates or economic slowdowns, which can negatively impact smaller companies that often rely on borrowing and are more sensitive to market conditions. Regulatory changes or sector-specific disruptions could also influence the performance of key industries within the ETF.

RSSL Top 10 Holdings

The Global X Russell 2000 ETF (RSSL) is leaning heavily into U.S. small-cap stocks, with a notable tilt toward healthcare, financials, and industrials. Guardant Health is a bright spot, riding strong technical momentum and earnings performance, while Bloom Energy and Credo Technology are lagging due to valuation concerns and bearish trends. IonQ, despite its innovative quantum computing focus, is dragging the fund with financial losses and weak technicals. Overall, the ETF’s diverse sector exposure offers growth potential, but its reliance on smaller, riskier names means performance can be a mixed bag.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Credo Technology Group Holding Ltd0.80%$10.71M$26.67B220.48%
70
Outperform
Bloom Energy0.73%$9.83M$22.30B260.30%
63
Neutral
Fabrinet0.54%$7.21M$15.39B76.79%
75
Outperform
Guardant Health0.47%$6.37M$14.08B210.00%
58
Neutral
IonQ0.46%$6.20M$16.67B51.42%
50
Neutral
NEXTracker, Inc. Class A0.45%$6.07M$13.36B131.70%
78
Outperform
Kratos Defense0.44%$5.92M$12.67B172.06%
61
Neutral
BridgeBio Pharma0.40%$5.32M$13.61B161.09%
55
Neutral
Madrigal Pharmaceuticals0.39%$5.23M$13.45B75.82%
56
Neutral
The Ensign Group0.37%$4.97M$10.86B28.46%
78
Outperform

RSSL Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
95.38
Positive
100DMA
92.31
Positive
200DMA
86.17
Positive
Market Momentum
MACD
-0.33
Negative
RSI
58.45
Neutral
STOCH
87.01
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RSSL, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 94.33, equal to the 50-day MA of 95.38, and equal to the 200-day MA of 86.17, indicating a bullish trend. The MACD of -0.33 indicates Negative momentum. The RSI at 58.45 is Neutral, neither overbought nor oversold. The STOCH value of 87.01 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RSSL.

RSSL Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$1.34B0.08%
$8.69B0.25%
$3.62B0.59%
$2.99B0.10%
$2.94B0.28%
$2.56B0.15%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
RSSL
Global X Russell 2000 ETF
97.08
3.18
3.39%
FNDA
Schwab Fundamental US Small Co. Index ETF
CALF
Pacer US Small Cap Cash Cows 100 ETF
VIOO
Vanguard S&P Small-Cap 600 ETF
FESM
Fidelity Enhanced Small Cap ETF
SMLF
iShares MSCI USA Small-Cap Multifactor ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement